SME3110 (Fluvoxamine Maleate) in the Treatment of Depression/Depressive State : A Post-Marketing Clinical Study in Children and Adolescents (8 Through 18 Years of Age) -A Double-Blind, Randomized, Placebo-Controlled Study.
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Fluvoxamine (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Sponsors Solvay Pharmaceuticals
- 14 Jul 2009 Actual patient number (90) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Actual initiation date changed from Jun 2006 to Oct 2006 as reported by ClinicalTrials.gov.
- 14 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.